Outreach & Events
In line with our mission to expand opportunities by which we can drive the advancements and breakthroughs currently taking place in the life science research and development space we created Science Shaping Our World – SHOWTM.
SHOWTM, is an ongoing seminar/networking series that highlights cutting edge life science research and translation. Together with our collaborative partners, the Harvard Catalyst Laboratory for Innovative Translational Technologies (HC-LITT), we seek to bring science, technology, and multidisciplinary networking to an even wider and more diverse audience, spanning a greater depth and breadth of life science research, translation, and development topics.
Additionally, throughout the year we sponsor, put-on, and take part in a number of science, technology, networking, and entrepreneurial events such as the Life Science Innovation & Technology Forum (IGNITE) piloted in 2011 in partnership with Biotech Vendor Services.
These events are a great opportunity to meet our team, reconnect with old colleagues, and meet new colleagues, as well as lend your voice, thoughts, and insight to the life science community working to bridge bench to bedside.
Science Shaping Our World (SHOW)
| Date | City | Venue |
|---|---|---|
| 03/29/12 | Science Shaping Our World (SHOW) in Boston, Massachusetts 02115 | TMEC Walter Amphitheater |
| Time: 6:00pm. Admission: Attendance is Free but Pre-regis. Address: 260 Longwood Ave. Venue phone: 617-252-8713. Science Shaping Our World (SHOW) is an ongoing seminar and networking series that highlights cutting edge translational life science research and development. Our mission is to bring together a multidisciplinary audience spanning academia and industry where they can gain exposure and insight into the life science advancements changing our world. Further, we seek to promote active inter and cross-disciplinary networking toward fostering the creation of novel opportunities in life science. March’s SHOW will focus on the growing trend in microbial drug resistance. Pathogenic bacteria resistant to many or all antibiotics already exist. Coupled with the rapid decline in microbiological research at pharmaceutical companies, the rapid rate at which resistance has evolved and spread has demanded a novel approach to addressing this critical human health issue. Buy tickets | ||
